1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-Hematological Cancer Treatment Revenue
1.4 Market by Type
1.4.1 Global Non-Hematological Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Surgery
1.4.4 Radiation Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Non-Hematological Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Oncology Treatment Centre
1.5.4 Ambulatory Surgery Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Non-Hematological Cancer Treatment Market Perspective (2015-2026)
2.2 Global Non-Hematological Cancer Treatment Growth Trends by Regions
2.2.1 Non-Hematological Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-Hematological Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Non-Hematological Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Non-Hematological Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Non-Hematological Cancer Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Non-Hematological Cancer Treatment Players by Market Size
3.1.1 Global Top Non-Hematological Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Non-Hematological Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Non-Hematological Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-Hematological Cancer Treatment Market Concentration Ratio
3.2.1 Global Non-Hematological Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Non-Hematological Cancer Treatment Revenue in 2019
3.3 Non-Hematological Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Non-Hematological Cancer Treatment Product Solution and Service
3.5 Date of Enter into Non-Hematological Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Non-Hematological Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Non-Hematological Cancer Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Non-Hematological Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Non-Hematological Cancer Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Non-Hematological Cancer Treatment Market Size (2015-2020)
6.2 Non-Hematological Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Non-Hematological Cancer Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Non-Hematological Cancer Treatment Market Size (2015-2020)
7.2 Non-Hematological Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Non-Hematological Cancer Treatment Market Size by Application (2015-2020)
8 China
8.1 China Non-Hematological Cancer Treatment Market Size (2015-2020)
8.2 Non-Hematological Cancer Treatment Key Players in China (2019-2020)
8.3 China Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
8.4 China Non-Hematological Cancer Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Non-Hematological Cancer Treatment Market Size (2015-2020)
9.2 Non-Hematological Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Non-Hematological Cancer Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Non-Hematological Cancer Treatment Market Size (2015-2020)
10.2 Non-Hematological Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Non-Hematological Cancer Treatment Market Size by Application (2015-2020)
11 India
11.1 India Non-Hematological Cancer Treatment Market Size (2015-2020)
11.2 Non-Hematological Cancer Treatment Key Players in India (2019-2020)
11.3 India Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
11.4 India Non-Hematological Cancer Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Non-Hematological Cancer Treatment Market Size (2015-2020)
12.2 Non-Hematological Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Non-Hematological Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Non-Hematological Cancer Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Non-Hematological Cancer Treatment Introduction
13.1.4 Novartis Revenue in Non-Hematological Cancer Treatment Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Non-Hematological Cancer Treatment Introduction
13.2.4 Pfizer Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview
13.3.3 Bristol-Myers Squibb Non-Hematological Cancer Treatment Introduction
13.3.4 Bristol-Myers Squibb Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Non-Hematological Cancer Treatment Introduction
13.4.4 Johnson & Johnson Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Non-Hematological Cancer Treatment Introduction
13.5.4 Roche Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.5.5 Roche Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Non-Hematological Cancer Treatment Introduction
13.6.4 Amgen Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Astellas Pharma
13.7.1 Astellas Pharma Company Details
13.7.2 Astellas Pharma Business Overview
13.7.3 Astellas Pharma Non-Hematological Cancer Treatment Introduction
13.7.4 Astellas Pharma Revenue in Non-Hematological Cancer Treatment Business (2015-2020)
13.7.5 Astellas Pharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Novartis、Pfizer、Bristol-Myers Squibb、Johnson & Johnson、Roche、Amgen、Astellas Pharma
【免責事項】
https://www.globalresearch.jp/disclaimer